Home > Financial Ratios > BAL PHARMA

BAL PHARMA
EV/Core EBITDA

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 7.838.728.867.2123.47

What is the latest EV/Core EBITDA ratio of BAL PHARMA ?

The latest EV/Core EBITDA ratio of BAL PHARMA is 7.83 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20247.83
Mar20238.72
Mar20228.86
Mar20217.21
Mar202023.47

How is EV/Core EBITDA of BAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 7.83
-10.21
Mar2023 8.72
-1.58
Mar2022 8.86
22.88
Mar2021 7.21
-69.28
Mar2020 23.47 -

Other Financial Ratios of BAL PHARMA


Compare EV/Core EBITDA ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹163.9 Cr -7.8% 10.4% 4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-7.8%

10.4%

4.6%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses